ARDX
ARDX
NASDAQ · Biotechnology

Ardelyx Inc

$7.05
+0.07 (+1.00%)
As of May 9, 1:32 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +568.7% upside
Low Target $33.22
Average Target $47.14
High Target $55.45
Current Price $7.05
Current
$7.05
Target
$47.14
$33.22 $47.14 avg $55.45
Scenario Analysis
Bear Case
$33.22
371.2%
Low target
Base Case
$47.14
+568.7%
Avg target
Bull Case
$55.45
+686.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$8.40
-16.1% from high
52-Week Low
$3.21
+119.6% from low
Target vs 52W High
$47.14
+461.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%